1. Home
  2. HALO vs EMN Comparison

HALO vs EMN Comparison

Compare HALO & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • EMN
  • Stock Information
  • Founded
  • HALO 1998
  • EMN 1920
  • Country
  • HALO United States
  • EMN United States
  • Employees
  • HALO N/A
  • EMN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • EMN Major Chemicals
  • Sector
  • HALO Health Care
  • EMN Industrials
  • Exchange
  • HALO Nasdaq
  • EMN Nasdaq
  • Market Cap
  • HALO 7.6B
  • EMN 7.2B
  • IPO Year
  • HALO N/A
  • EMN 1993
  • Fundamental
  • Price
  • HALO $68.24
  • EMN $61.13
  • Analyst Decision
  • HALO Buy
  • EMN Buy
  • Analyst Count
  • HALO 11
  • EMN 13
  • Target Price
  • HALO $74.91
  • EMN $80.62
  • AVG Volume (30 Days)
  • HALO 2.2M
  • EMN 3.4M
  • Earning Date
  • HALO 11-03-2025
  • EMN 11-03-2025
  • Dividend Yield
  • HALO N/A
  • EMN 5.42%
  • EPS Growth
  • HALO 56.68
  • EMN N/A
  • EPS
  • HALO 4.74
  • EMN 6.01
  • Revenue
  • HALO $1,242,852,000.00
  • EMN $9,024,000,000.00
  • Revenue This Year
  • HALO $32.47
  • EMN N/A
  • Revenue Next Year
  • HALO $24.31
  • EMN $2.07
  • P/E Ratio
  • HALO $14.41
  • EMN $10.19
  • Revenue Growth
  • HALO 31.19
  • EMN N/A
  • 52 Week Low
  • HALO $42.01
  • EMN $56.75
  • 52 Week High
  • HALO $79.50
  • EMN $107.50
  • Technical
  • Relative Strength Index (RSI)
  • HALO 56.09
  • EMN 48.10
  • Support Level
  • HALO $67.40
  • EMN $59.38
  • Resistance Level
  • HALO $66.97
  • EMN $61.92
  • Average True Range (ATR)
  • HALO 2.04
  • EMN 1.84
  • MACD
  • HALO 0.51
  • EMN 0.07
  • Stochastic Oscillator
  • HALO 71.78
  • EMN 59.06

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

Share on Social Networks: